Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The third International Scientific Tendinopathy Symposium - New Approaches to Tendon Therapeutics - is being held in St Hilda's College, Oxford, on Friday 5 and Saturday 6 September. The event brings together an unprecedented mix of excellent basic and translational science and the finest clinical expertise.

The third International Scientific Tendinopathy Symposium - New Approaches to Tendon Therapeutics - is being held in St Hilda's College, Oxford, on Friday 5 and Saturday 6 September. The event brings together an unprecedented mix of excellent basic and translational science and the finest clinical expertise.

In addition to the scientific meeting, featuring twelve international plenary speakers, along with open papers and poster sessions, there will be two satellite events on Sunday 7 September - a hands-on clinical workshop on tendinopathy and a consensus meeting on outcome measures.

The meeting has proved highly popular and is now fully booked, but you can follow the meeting and join the discussion on Twitter using hashtag #Tendons2014.

The Symposium is co-chaired by NDORMS Head of Department Professor Andrew Carr, Associate Professor Philippa Hulley, also of NDORMS and Associate Professor Mark Thompson, of the Institute of Biomedical Engineering, Oxford.

Speaking of the event, Prof Thompson says: "ISTS 2014 will pull together exciting plenary speakers, excellent scientists and expert clinicians in the inspiring surroundings of St Hilda's College to find new ways of treating painful and debilitating tendon disease. The meeting venue is full, but social media will take the conversations wider and further, and we will be posting video of the final discussion session."

The meeting proceedings will be published in the BJSM soon after the event.

For the first time in its three-edition history, the meeting is co-sponsored by the International Symposium on Ligaments and Tendons, while the commercial sponsors are the British Journal of Sports Medicine (BJSM), UTC Imaging BV, TRB Chemedica, Biomet, Mathys, RegenLab and Bose.

Prof Thompson has already spoken to BJSM about this year's Symposium and a podcast is online. This year's programme is also published.

Similar stories

Yoshi Itoh wins the International Dupuytren Award 2022

Yoshi Itoh, Associate Professor and Principal Investigator Cell Migration Group at the Kennedy Institute has been awarded the International Dupuytren Award 2022.

Taking a break from immune-suppressing medicines doubles the antibody response to COVID-19 booster vaccination

The Oxford Clinical Trials Research Unit (OCTRU) at NDORMS played a key role in the VROOM study which found that pausing immune-suppressing medicines such as methotrexate can increase the response to COVID-19 booster jabs.

Ten Years of Athena Swan in the Medical Sciences Division

2022 marks ten years since the first Athena Swan Bronze applications from the Medical Sciences Division. Ten years later, and all 16 departments in the Division have achieved a Silver Award. We look at NDORMS’ Athena Swan journey.

NDORMS researchers awarded Associate Professor title

The University of Oxford has awarded the title of Associate Professor to Adam Cribbs and Luke Jostins.

Oxford's largest ever study into varicose veins shows need for surgery is linked to genetics

A new international study by Oxford researchers published in Nature Communications, establishes for the first time a critical genetic risk score to predict the likelihood of patients suffering with varicose veins to require surgery, as well as pointing the way towards potential new therapies.

Reflecting on the role of Clinical Director of Trauma and Orthopaedics

In 2021 Professor Andrew Price was appointed Clinical Director of Trauma and Orthopaedics at the Oxford University Hospitals NHS Foundation Trust. After 9 months in post, we find out what the challenges are and what he’s been able to bring to the role.